Corrigendum to ‘Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways’. [Int. Immunopharmacol. 75 (2019) 105739]